Patent ID: 11890336
Assignee: LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 6:
7. An antigenic polypeptide, comprising:
a carrier polypeptide comprising at least 95% identity over the full length amino acid sequence of SEQ ID NO: 3, and
an O-antigen antigenic polysaccharide isolated from Francisella crosslinked to the carrier polypeptide;
wherein the O-antigen comprises
4)-α-D-GalNAcAN-(1-4)-α-D-GalNAcAN-(1-3)-β-D-GlcNAc-(1-2)-β-D-Qui4NFm-(1-), and
wherein GalNacAN is 2-acetomido-2-deoxy-O-D-galacturonamide, Qui4NFm is 4,6-dideoxy-4-formamido-D-glucose, and the reducing end group GlcNAc is N-acetyl glucosamine.